Blood-based genomic profiling of circulating cell-free tumor DNA (ctDNA) in 1397 patients (pts) with colorectal cancer (CRC).

被引：1
|
作者：
Strickler, John H.
Banks, Kimberly C.
Nagy, Rebecca J.
Lanman, Richard B.
Talasaz, AmirAli
Corcoran, Ryan Bruce
Kopetz, Scott
机构：
[1] Duke Univ, Med Ctr, Durham, NC USA
[2] Guardant Hlth Inc, Redwood City, CA USA
[3] Massachusetts Gen Hosp, Boston, MA 02114 USA
[4] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷 / 04期
关键词：
D O I：
10.1200/JCO.2017.35.4_suppl.584
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
584
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Comparative circulating tumor DNA (ctDNA) genomic profiling in 110 patients with advanced renal cell carcinoma
    Kotecha, Ritesh
    Gedvilaite, Erika
    Murray, Samuel J.
    Foster, Ashley
    Motzer, Robert J.
    Tsui, Dana
    Voss, Martin H.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [42] Genomic profiling of metastatic prostate cancer through analysis of circulating tumor DNA (ctDNA).
    Gourdin, Theodore Stewart
    Lilly, Michael B.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [43] Review of Blood-Based Colorectal Cancer Screening: How Far Are Circulating Cell-Free DNA Methylation Markers From Clinical Implementation?
    Orntoft, Mai-Britt Worm
    CLINICAL COLORECTAL CANCER, 2018, 17 (02) : E415 - E433
  • [44] Cell-Free Circulating Mitochondrial DNA: A Potential Blood-Based Marker for Atrial Fibrillation
    Wiersma, Marit
    van Marion, Denise M. S.
    Bouman, Emma J.
    Li, Jin
    Zhang, Deli
    Ramos, Kennedy S.
    Lanters, Eva A. H.
    de Groot, Natasja M. S.
    Brundel, Bianca J. J. M.
    CELLS, 2020, 9 (05)
  • [45] Discovery and validation of methylation signatures in blood-based circulating tumor cell-free DNA in early detection of colorectal carcinoma: a case–control study
    Jinke Sui
    Xianrui Wu
    Chenyang Wang
    Guoqiang Wang
    Chengcheng Li
    Jing Zhao
    Yuzi Zhang
    Jianxing Xiang
    Yu Xu
    Weiqi Nian
    Fuao Cao
    Guanyu Yu
    Zheng Lou
    Liqiang Hao
    Lianjie Liu
    Bingsi Li
    Zhihong Zhang
    Shangli Cai
    Hao Liu
    Ping Lan
    Wei Zhang
    Clinical Epigenetics, 2021, 13
  • [46] Impact of a metastatic site on circulating tumor DNA (ctDNA) analysis in patients (pts) with metastatic colorectal cancer (mCRC).
    Bando, Hideaki
    Nakamura, Yoshiaki
    Taniguchi, Hiroya
    Shiozawa, Manabu
    Yasui, Hisateru
    Esaki, Taito
    Ohta, Takashi
    Denda, Tadamichi
    Satoh, Taroh
    Yamazaki, Kentaro
    Sunakawa, Yu
    Kato, Takeshi
    Goto, Masahiro
    Yuki, Satoshi
    Nishina, Tomohiro
    Oki, Eiji
    Shinozaki, Eiji
    Matsuhashi, Nobuhisa
    Hata, Masayuki
    Yoshino, Takayuki
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [47] Blood-Based Analyses of Cancer: Circulating Tumor Cells and Circulating Tumor DNA
    Haber, Daniel A.
    Velculescu, Victor E.
    CANCER DISCOVERY, 2014, 4 (06) : 650 - 661
  • [48] Blood-based monitoring of mutation burden in pancreato-biliary malignancies via profiling circulating tumor DNA (ctDNA).
    Pittella-Silva, Fabio
    Motoya, Masayo
    Kimura, Yasutoshi
    Nakamura, Toru
    Imamura, Masafumi
    Nagayama, Minoru
    Low, Siew-Kee
    Nakamura, Yusuke
    CANCER SCIENCE, 2021, 112 : 762 - 762
  • [49] Cell-free circulating tumor DNA monitoring in pancreatic cancer patients
    Balendran-Braun, S.
    Kieler, M.
    Liebmann-Reindl, S.
    Prager, G. W.
    Streubel, B.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 455 - 455
  • [50] A plasma-only integrated genomic and epigenomic circulating tumor DNA (ctDNA) assay to inform recurrence risk in colorectal cancer (CRC).
    Parikh, Aparna Raj
    Van Seventer, Emily E.
    Boland, Genevieve Marie
    Hartwig, Anna
    Jaimovich, Ariel
    Raymond, Victoria M.
    Talasaz, AmirAli
    Corcoran, Ryan Bruce
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
12345